ELI LILLY & Co Share-Based Compensation 2007-2026 | LLY
Beta
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is ELI LILLY & Co's current share-based compensation?
ELI LILLY & Co (LLY) annual share-based compensation for 2025 was $626.0M, a 3.10% decline from 2024. ELI LILLY & Co share-based compensation for the quarter ending March 31, 2026 was $161.0M.
What was ELI LILLY & Co's share-based compensation in 2024?
ELI LILLY & Co annual share-based compensation for 2024 was $646.0M, a 2.70% increase from 2023.
What was ELI LILLY & Co's share-based compensation in 2023?
ELI LILLY & Co annual share-based compensation for 2023 was $629.0M, a 69.50% increase from 2022.
What is ELI LILLY & Co's 5-year share-based compensation CAGR?
ELI LILLY & Co share-based compensation grew at a compound annual growth rate (CAGR) of 15.23% from FY2020 to FY2025, going from $308.1M to $626.0M over 5 years.
Share-Based Compensation History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+15.2%
FY2020
$308.1M
→
FY2025
$626.0M
07080910111213141516171819202122232425
5 years selected
Share-Based Compensation History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $626.0M | -3.1% | 10-K |
| FY2024 | $646.0M | +2.7% | 10-K |
| FY2023 | $629.0M | +69.5% | 10-K |
| FY2022 | $371.1M | +8.3% | 10-K |
| FY2021 | $342.8M | +11.3% | 10-K |
| FY2020 | $308.1M | -1.4% | 10-K |
| FY2019 | $312.4M | +11.8% | 10-K |
| FY2018 | $279.5M | -0.6% | 10-K |
| FY2017 | $281.3M | +10.2% | 10-K |
| FY2016 | $255.3M | +17.2% | 10-K |
| FY2015 | $217.8M | +39.6% | 10-K |
| FY2014 | $156.0M | +7.7% | 10-K |
| FY2013 | $144.9M | +2.4% | 10-K |
| FY2012 | $141.5M | -4.0% | 10-K |
| FY2011 | $147.4M | -36.2% | 10-K |
| FY2010 | $231.0M | -37.3% | 10-K |
| FY2009 | $368.5M | +44.3% | 10-K |
| FY2008 | $255.3M | +190.5% | 10-K |
| FY2007 | $-282.0M | - | 10-K |
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →